A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liège, Belgium. J. Clin. Endocrinol. Metab. 91, 4769–4775 (2006)
A.F. Daly, M.A. Tichomirowa, A. Beckers, Genetic, molecular and clinical features of familial isolated pituitary adenomas. Horm. Res. 71, 116–122 (2009)
L. Rostomyan, A. Beckers, Screening for genetic causes of growth hormone hypersecretion. Growth Horm. IGF Res. (2016) Published online early on 12 Oct 2016. pii: S1096-6374(16)30062-4. (in press). doi:10.1016/j.ghir.2016.10.004. [Epub ahead of print]
A. Beckers, M.B. Lodish, G. Trivellin, L. Rostomyan, M. Lee, F.R. Faucz, B. Yuan, C.S. Choong, J.-H. Caberg, E. Verrua, L.A. Naves, T.D. Cheetham, J. Young, P.A. Lysy, P. Petrossians, A. Cotterill, N.S. Shah, D. Metzger, E. Castermans, M.R. Ambrosio, C. Villa, N. Strebkova, N. Mazerkina, S. Gaillard, G.B. Barra, L.A. Casulari, S.J. Neggers, R. Salvatori, M.-L. Jaffrain-Rea, M. Zacharin, B.L. Santamaria, S. Zacharieva, E.M. Lim, G. Mantovani, M.C. Zatelli, M.T. Collins, J.-F. Bonneville, M. Quezado, P. Chittiboina, E.H. Oldfield, V. Bours, P. Liu, W.W. De Herder, N. Pellegata, J.R. Lupski, A.F. Daly, C.A. Stratakis, X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr. Relat. Cancer. 22, 353–367 (2015)
C. Ramírez-Rentería, L.C. Hernández-Ramírez, L. Portocarrero-Ortiz, G. Vargas, V. Melgar, E. Espinosa, A.L. Espinosa-de-Los-Monteros, E. Sosa, B. González, S. Zúñiga, M. Unterländer, J. Burger, K. Stals, A.-M.M. Bussell, S. Ellard, M. Dang, D. Iacovazzo, S. Kapur, P. Gabrovska, S. Radian, F. Roncaroli, M. Korbonits, M. Mercado, AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience. Endocrine 53, 402–411 (2016)
O. Vierimaa, M. Georgitsi, R. Lehtonen, P. Vahteristo, A. Kokko, A. Raitila, K. Tuppurainen, T.M. Ebeling, P.I. Salmela, R. Paschke, S. Gundogdu, E. De Menis, M.J. Makinen, V. Launonen, A. Karhu, L.A. Aaltonen, Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312, 1228–1230 (2006)
G. Occhi, M.L. Jaffrain-Rea, G. Trivellin, N. Albiger, F. Ceccato, E. De Menis, M. Angelini, S. Ferasin, A. Beckers, F. Mantero, C. Scaroni, The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: mutational hot-spot or founder effect? J. Endocrinol. Invest 33, 800–805 (2010)
H.S. Chahal, K. Stals, M. Unterlander, D.J. Balding, M.G. Thomas, A.V. Kumar, G.M. Besser, A.B. Atkinson, P.J. Morrison, T.A. Howlett, M.J. Levy, S.M. Orme, S.A. Akker, R.L. Abel, A.B. Grossman, J. Burger, S. Ellard, M. Korbonits, AIP mutation in pituitary adenomas in the 18th century and today. N. Engl. J. Med. 364, 43–50 (2011)
A.F. Daly, A. Beckers, Familial Isolated Pituitary Adenomas (FIPA) and Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene. Endocrinol. Metab. Clin. North Am. 44, 19–25 (2016)
A.F. Daly, M.A. Tichomirowa, P. Petrossians, E. Heliövaara, M.-L. Jaffrain-Rea, A. Barlier, L.A. Naves, T. Ebeling, A. Karhu, A. Raappana, L. Cazabat, E. De Menis, C.F. Montañana, G. Raverot, R.J. Weil, T. Sane, D. Maiter, S. Neggers, M. Yaneva, A. Tabarin, E. Verrua, E. Eloranta, A. Murat, O. Vierimaa, P.I. Salmela, P. Emy, R.A. Toledo, M.I. Sabaté, C. Villa, M. Popelier, R. Salvatori, J. Jennings, Á.F. Longás, J.I.L. Aizpún, M. Georgitsi, R. Paschke, C. Ronchi, M. Valimaki, C. Saloranta, W. De Herder, R. Cozzi, M. Guitelman, F. Magri, M.S. Lagonigro, G. Halaby, V. Corman, M.-T. Hagelstein, J.-F. Vanbellinghen, G.B. Barra, A.-P. Gimenez-Roqueplo, F.J. Cameron, F. Borson-Chazot, I. Holdaway, S.P.A. Toledo, G.K. Stalla, A. Spada, S. Zacharieva, J. Bertherat, T. Brue, V. Bours, P. Chanson, L.A. Aaltonen, A. Beckers, Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J. Clin. Endocrinol. Metab. 95, E373–E383 (2010)
M.-L. Jaffrain-Rea, M. Angelini, D. Gargano, M.A. Tichomirowa, A.F. Daly, J.-F. Vanbellinghen, E. D’Innocenzo, A. Barlier, F. Giangaspero, V. Esposito, L. Ventura, A. Arcella, M. Theodoropoulou, L.A. Naves, C. Fajardo, S. Zacharieva, V. Rohmer, T. Brue, A. Gulino, G. Cantore, E. Alesse, A. Beckers, Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. Endocr. Relat. Cancer 16, 1029–1043 (2009)
L. Kasuki Jomori de Pinho, L. Vieira Neto, L.E. Armondi Wildemberg, E.L. Gasparetto, J. Marcondes, B. de Almeida Nunes, C.M. Takiya, M.R. Gadelha, Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53. Neuroendocrinology 94, 39–48 (2011)
L. Rostomyan, A.F. Daly, P. Petrossians, E. Nachev, A.R. Lila, A.-L. Lecoq, B. Lecumberri, G. Trivellin, R. Salvatori, A.G. Moraitis, I. Holdaway, D.J. Kranenburg-Van Klaveren, M.C. Zatelli, N. Palacios, C. Nozieres, M. Zacharin, T. Ebeling, M. Ojaniemi, L. Rozhinskaya, E. Verrua, M.-L. Jaffrain-Rea, S. Filipponi, D. Gusakova, V. Pronin, J. Bertherat, Z. Belaya, I. Ilovayskaya, M. Sahnoun-Fathallah, C. Sievers, G.K. Stalla, E. Castermans, J.-H. Caberg, E. Sorkina, R.S. Auriemma, S. Mittal, M. Kareva, P.A. Lysy, P. Emy, E. De Menis, C.S. Choong, G. Mantovani, V. Bours, W. De Herder, T. Brue, A. Barlier, S.J.C.M.M. Neggers, S. Zacharieva, P. Chanson, N.S. Shah, C.A. Stratakis, L.A. Naves, A. Beckers, Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr. Relat. Cancer 22, 745–757 (2015)
